Drug intelligence / Profile preview

senna + gastrofin; sodium picosulfate + magnesium citrate

Development stage
Unknown
Lead developer
Ferring Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

This entry refers to a combination of two multi-agent bowel preparation regimens, each used for gastrointestinal cleansing prior to procedures such as colonoscopy. The first regimen, "senna + gastrofin," combines senna (a stimulant laxative derived from Senna alexandrina) with Gastrofin (likely referring to Gastrografin, a contrast agent containing diatrizoate meglumine and diatrizoate sodium). Senna increases intestinal motility and fluid secretion in the colon, promoting bowel evacuation[1][5]. Gastrografin is an oral or rectal radiopaque contrast medium that also has osmotic laxative properties[3]. The second regimen, "sodium picosulfate + magnesium citrate," is a well-established oral bowel cleansing agent. Sodium picosulfate acts as a stimulant laxative by increasing peristalsis in the colon, while magnesium citrate acts as an osmotic laxative by drawing water into the intestines[6][8][10]. This combination induces watery diarrhea for effective colonic cleansing before diagnostic procedures. Both regimens are used primarily for short-term bowel preparation and not recommended for chronic use due to risks of electrolyte imbalance.

Brand names
ClenpiqPrepopikCitraFleetPicolax
Other names
sennosides + gastrografin; sodium picosulfate/magnesium citrate

Beyond the preview

Go deeper on senna + gastrofin; sodium picosulfate + magnesium citrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on senna + gastrofin; sodium picosulfate + magnesium citrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call